Thermo Fisher Scientific Inc.

01/03/2020 | Press release | Distributed by Public on 01/03/2020 07:19

Thermo Fisher Scientific to Present at 38th Annual J.P. Morgan Healthcare Conference on January 13, 2020

Thermo Fisher Scientific to Present at 38th Annual J.P. Morgan Healthcare Conference on January 13, 2020

WALTHAM, Mass., Jan. 3, 2020/PRNewswire / -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Monday, January 13, 2020, at 4:00 p.m. (PST)followed by a Q&A session at 4:30 p.m. (PST).

You can access the webcast of the presentation and the Q&A session via the Investors section of our website, www.thermofisher.com.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $24billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands - Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services - we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Media Contact Information:
Ron O'Brien
Phone: 781-622-1242
E-mail: [email protected]
Website: www.thermofisher.com

Investor Contact Information:
Ken Apicerno
Phone: 781-622-1294
E-mail: [email protected]

SOURCE Thermo Fisher Scientific